Lessons for health technology assessment: It is not only about the evidence

Value in Health

Volumn 12, Issue SUPPL. 2, 2009, Pages

  Neumann, Peter J ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Health care decisions; HTA

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROGRAM; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; SOCIOECONOMICS;

EID: 66549109448     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2009.00558.x     Document Type: Article

References (28)

1. The European network for health technology assessment. Background, aims, organisation. 2008. Available from: http://www.eunethta.net/ [Accessed April 29, 2008].
2. Sorenson C, Kanavos P, Drummond M. Ensuring Value for Money in Health Care: The Role of HTA in the European Union. Copenhaguen : European Observatory on Health Systems and Policies - World Health Organisation, 2008.
3. Hutton J, McGrath C, Frybourg JM, et al. Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems). Int J Technol Assess Health Care 2006 22 : 10 18. (Pubitemid 43376234)
4. Garcia-Altes A, Ondategui-Parra S, Neumann PJ. Cross-national comparison of technology assessment processes. Int J Technol Assess Health Care 2004 20 : 300 10.
5. Drummond M. International guidelines for pharmaceocnomic analyses: vive la difference? ISPOR CONNECTIONS Nov/Dec 15 2006. Lawrenceville, NJ : ISPOR, 2006.
6. Neumann PJ. American exceptionalism and American health care: implications for the U.S. debate on cost-effectiveness analysis. Office of Health Economics OHE Briefing No. 47, London, January 2007.
7. Kohut A, Stokes B. America Against the World: How We Are Different and Why We Are Disliked. New York : Times Books, 2006.
8. Cohen J, Cairns C, Paquette C, Faden L. Comparing patient access to pharmaceuticals in the UK and US. Appl Health Econ Health Policy 2006 5 : 177 87.
9. Perry S. Special report. The brief life of the National Center for Health Care Technology. N Engl J Med 1982 307 : 1095 100.
10. Blumenthal D. Federal policy toward health care technology: the case of the National Center. Milbank Mem Fund Q Health Soc 1983 61 : 584 613.
11. Gray BH, Gusmano MK, Collins SR. AHCPR and the changing politics of health services research. Health Aff (Millwood) 2003 Suppl. Web Exclusives W3 307.
12. Deyo RA, Psaty BM, Simon G, et al. The messenger under attack - intimidation of researchers by special-interest groups. N Engl J Med 1997 336 : 1176 80.
13. Neumann PJ, Kamae MS, Palmer JA. Medicare's national coverage decisions for technologies, 1999-2007. Health Aff 2008 27 : 1620 31.
14. Drug Effectiveness Review Project. Oregon Health and Science University. 2007. Available from: http://www.ohsu.edu/drugeffectiveness/index.htm [Accessed April 29, 2008].
15. Gordon C. Dead on Arrival: The Politics of Health Care in Twentieth Century America. Princeton : Princeton University Press, 2003.
16. Broyles RW, Falcone DJ. Health care reform? An American obsession with prescriptive incrementalism. J Health Hum Serv Adm 1996 18 : 328 52.
17. Claxton K, Cohen JT, Neumann PJ. When is evidence sufficient? Health Aff (Milwood) 2005 24 : 93 101. (Pubitemid 40169776)
18. Neumann PJ. Why don't Americans use cost-effectiveness analysis? Am J Manag Care 2004 10 : 308 12.
19. Neumann PJ, Sullivan SD. Economic evaluation in the US: what is the missing link? Pharmacoeconomics 2006 24 : 1163 8.
20. Mohr P. Use of cost-effectiveness analysis in the US medicare program. December 4, 2006. Presentation at Harvard School of Public Health. Boston, MA.
21. Neumann PJ. Emerging lessons from the Drug Effectiveness Review Project. Health Aff (Millwood) 2006 25 : W262 71.
22. Garrison LP Jr., Neumann PJ, Erickson P, et al. Using real-world data for coverage and payment decisions: the ISPOR real-world data task force report. Value Health 2007 10 : 326 35.
23. Drummond M. Evidence for coverage decisions: the need for a reality check. Value Health 2007 10 : 321. (Pubitemid 47481114)
24. Gotzsche PC, Hrobjartsson A, Maric K, Tendal B. Data extraction errors in meta-analyses that use standardized mean differences. JAMA 2007 298 : 430 7.
25. Norris SL, Atkins D. Challenges in using nonrandomized studies in systematic reviews of treatment interventions. Ann Intern Med 2005 142 (12 Pt 2 1112 9.
26. Drummond M, Schwartz JS, Jonsson B, et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care 2008 (In press).
27. Laine C, Horton R, DeAngelis CD, et al. Clinical trial registration: looking back and moving ahead. JAMA 2007 298 : 93 4.
28. Tannen D. You Just Don't Understand. New York : William Morrow and Company, 1990.